Literature DB >> 16391894

A case of mixed connective tissue disease complicated with thrombotic thrombocytopenic purpura.

Takeshi Kuroda1, Kouki Matsuyama, Takeshi Nakatsue, Syuuichi Murakami, Hisashi Hasegawa, Hideaki Nakayama, Minoru Sakatsume, Mitsuhiro Ueno, Masaaki Nakano, Fumitake Gejyo.   

Abstract

Thrombotic thrombocytopenic purpura (TTP) is a rare complication of mixed connective tissue disease (MCTD). In this report, we describe the case of a 73-year-old Japanese woman with MCTD who developed fever, thrombocytopenia, and microangiopathic hemolytic anemia and was diagnosed with MCTD together with TTP. The activity of von Willebrand factor (vWF) cleaving metalloprotease ADAMTS13 was low and considered to have contributed to the disease activity of TTP. The patient died despite intensive treatment of plasma exchange (PEX) and steroid pulse therapy. Autopsy results revealed that the kidneys had platelet and fibrin thrombi, which occluded capillaries and arterioles. These findings were compatible with TTP and the decreased activity of ADAMTS13 was considered to be associated with the disease activity of TTP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16391894     DOI: 10.1007/s10067-005-0105-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  16 in total

1.  Thrombotic thrombocytopenic purpura in a patient with rheumatoid arthritis treated by plasmapheresis.

Authors:  E M Kfoury Baz; R A Mahfouz; A F Masri
Journal:  Ther Apher       Date:  1999-11

Review 2.  Thrombotic microangiopathies.

Authors:  Joel L Moake
Journal:  N Engl J Med       Date:  2002-08-22       Impact factor: 91.245

3.  Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura.

Authors:  X Zheng; D Chung; T K Takayama; E M Majerus; J E Sadler; K Fujikawa
Journal:  J Biol Chem       Date:  2001-09-13       Impact factor: 5.157

4.  Vasculitis and thrombotic thrombocytopenic purpura in a patient with limited scleroderma.

Authors:  A Miller; P F Ryan; J P Dowling
Journal:  J Rheumatol       Date:  1997-03       Impact factor: 4.666

5.  Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura.

Authors:  H M Tsai; L Rice; R Sarode; T W Chow; J L Moake
Journal:  Ann Intern Med       Date:  2000-05-16       Impact factor: 25.391

6.  Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases.

Authors:  A Veyradier; B Obert; A Houllier; D Meyer; J P Girma
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

7.  Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.

Authors:  G G Levy; W C Nichols; E C Lian; T Foroud; J N McClintick; B M McGee; A Y Yang; D R Siemieniak; K R Stark; R Gruppo; R Sarode; S B Shurin; V Chandrasekaran; S P Stabler; H Sabio; E E Bouhassira; J D Upshaw; D Ginsburg; H M Tsai
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

8.  Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.

Authors:  H M Tsai; E C Lian
Journal:  N Engl J Med       Date:  1998-11-26       Impact factor: 91.245

9.  Thrombocytopenia and hemolytic anemia in a patient with mixed connective tissue disease due to thrombotic thrombocytopenic purpura.

Authors:  E J ter Borg; P M Houtman; C G Kallenberg; M A van Leeuwen; M H van Rÿswÿk
Journal:  J Rheumatol       Date:  1988-07       Impact factor: 4.666

10.  Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab.

Authors:  Jens Chemnitz; Andreas Draube; Christof Scheid; Peter Staib; Armin Schulz; Volker Diehl; Dietmar Söhngen
Journal:  Am J Hematol       Date:  2002-10       Impact factor: 10.047

View more
  1 in total

1.  Thrombotic thrombocytopenic purpura associated with mixed connective tissue disease: a case report.

Authors:  João Tadeu Damian Souto Filho; Philipe Vianna de Barros; Aline Maria Yamaguti Rios Paes da Silva; Fernanda Alves Barbosa; Gustavo Fernandes Ribas
Journal:  Case Rep Med       Date:  2011-09-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.